BKHA on Nasdaq
Black Hawk Acquisition Corp
Price unavailable
Last updated Oct 16, 2026.
Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Financial statements
Every line of the income statement in the latest annual report, as filed.3
| Period ending | 2025-11-30 | 2024-11-30 |
|---|---|---|
| General and administrative expenses | $795.5K | $492.1K |
| Related party administrative fees | $120.0K | $83.9K |
| Loss from Operations | -$915.5K | -$576.1K |
| Interest income | $1.8K | $7.5K |
| Interest earned on investments held in Trust Account | $2.3M | $2.5M |
| Interest expense | -$15.5K | |
| Change in fair value of derivative liability | $92 | |
| Total other income, net | $2.2M | $2.5M |
| Net income | $1.3M | $1.9M |
| Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption | 5.0M shares | 4.8M shares |
| Basic and diluted net income per share, Class A ordinary shares subject to possible redemption | $0.19 | $0.29 |
| Basic and diluted weighted average shares outstanding, non-redeemable Class A ordinary shares | 2.0M shares | 1.9M shares |
| Basic and diluted net income per share, non-redeemable Class A ordinary shares | $0.19 | $0.29 |
Every line of the balance sheet in the latest annual report, as filed.3
| Period ending | 2025-11-30 | 2024-11-30 |
|---|---|---|
| Cash | $39.5K | $264.8K |
| Prepaid expenses | $11.3K | $49.2K |
| Total Current Assets | $50.8K | $314.1K |
| Investments held in Trust Account | $23.8M | $71.8M |
| Total Assets | $23.9M | $72.1M |
| Due to target company | $575.0K | $0 |
| Accrued offering costs and expenses | $296.4K | $71.0K |
| Accrued interest expenses | $15.5K | |
| Convertible notes related party | $595.4K | $0 |
| Total Current Liabilities | $1.5M | $71.0K |
| Deferred underwriting fee payable | $2.4M | $2.4M |
| Total Liabilities | $3.9M | $2.5M |
| Class A ordinary shares subject to possible redemption, $0.0001 par value; 500,000,000 shares authorized; 6,900,000 shares and 6,900,000 share issued and outstanding at redemption value of $11.22 and $10.41 as of November 30, 2025 and 2024, respectively | $23.8M | $71.8M |
| Additional paid-in capital | $4.5K | |
| Accumulated deficit | -$3.9M | -$2.2M |
| Total Shareholders Deficit | -$3.8M | -$2.2M |
| Total Liabilities and Shareholders Deficit | $23.9M | $72.1M |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.3
| Period ending | 2025-11-30 | 2024-11-30 |
|---|---|---|
| Net income | $1.3M | $1.9M |
| Interest earned on investments held in Trust Account | -$2.3M | -$2.5M |
| Change in fair value of derivative liability | -$92 | |
| Prepaid expenses | $38.0K | -$49.2K |
| Accrued offering costs and expenses | $240.9K | $64.1K |
| Net Cash Used in Operating Activities | -$650.3K | -$553.7K |
| Purchase of investment held in Trust Account | -$69.3M | |
| Cash deposited in Trust Account | -$750.0K | |
| Cash withdrawn from Trust to pay redeemed public shareholders | $51.0M | |
| Net Cash Provided by (Used in) Investing Activities | $50.3M | -$69.3M |
| Proceeds from issuance of promissory note to related party | $600.0K | |
| Proceeds from due to target company | $575.0K | |
| Proceeds from sale of public units | $69.0M | |
| Proceeds from sale of private placement units | $2.4M | |
| Proceeds from issuance of ordinary shares to underwriter | $690.0K | |
| Proceeds from due from related party | $30.9K | |
| Payment of underwriter compensation | -$690.0K | |
| Repayment of promissory note - related party | -$250.0K | |
| Payment of offering costs | -$1.1M | |
| Payment to redeemed public shareholders | -$51.0M | |
| Net Cash (Used in) Provided by Financing Activities | -$49.8M | $70.0M |
| Net Change in Cash | -$225.3K | $139.7K |
| Issuance of convertible note - recognition of derivative liability | $4.6K | |
| Reclassification of Derivative Liability to APIC | $4.5K | |
| Conversion of Class B to Class A shares | $172 | |
| Initial classification of common stock subject to possible redemption | $69.3M | |
| Accretion of additional paid in capital to accumulated deficit | $1.7M | |
| Remeasurement of common stock subject to possible redemption | $3.0M | $2.5M |
| Deferred underwriting fee payable | $2.4M |
Recent filings
- Oct 13, 20268-K
- Oct 7, 2026SCHEDULE 13G/A
- Oct 6, 202610-Q
- Sep 25, 2026425
- Sep 24, 20268-K
- Sep 22, 2026424B4
- Sep 22, 20268-K
- Sep 17, 2026EFFECT
- Sep 4, 2026S-4/A
- Aug 26, 20268-K
- Aug 25, 20268-K
- Aug 3, 2026S-4/A
- Jul 22, 20268-K
- Jul 15, 202610-Q
- Jul 6, 2026S-4/A
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6